Loading clinical trials...
Loading clinical trials...
This is an open-label, parallel-group study with a total of 16 evaluable subjects. Subjects will be assigned to 1 of the following cohorts: Cohorts I (subjects with normal hepatic function; n+8 and Co...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genta Incorporated
NCT05718258 · Hepatic Function Abnormal
NCT07055412 · Pharmacokinetic Differences, Y-3, and more
NCT05283915 · Hepatic Function Abnormal
NCT02586194 · Patients With Impaired Hepatic Function
NCT00398424 · Impaired Hepatic Function
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions